a) In a far reaching move, Dr Samir K Brahmachari, Director-General, Council of Scientific and Industrial Research (CSIR) invited players in the medical technology sector to utilize the R&D platform being developed by the government for innovation and research in biomedical instrumentation.
Addressing the 5th Medical Technology Conference organized by the Confederation of Indian Industry (CII), he said that achieving affordable healthcare through instrumentation was a key action area in the 10-year CSIR roadmap recently presented to the Prime Minister. Early detection of disease by use of new technologies increases survival rate and reduces treatment cost considerably.
b) Dr Arun Kumar Panda, Joint Secretary, Ministry of Health & Family Welfare, informed that the legislation relating to medical devices had been drafted and sent to the law ministry for approval. So far regulatory requirements for the sector are under the Drugs & Cosmetics Act.
He requested the industry representatives to identify the areas in which the government could help them
realize their growth potential and at the same further healthcare goals. Responding to questions, Dr Panda
said the 12th Plan was likely to see a considerable increase in healthcare spending and upgradation of health
c) Dr Naresh Trehan, Chairman CII National Committee on Healthcare and Chairman & Managing Director, Medanta Medicity, called for technology innovation that would be useful at the base level and suggested that India should leverage the advances in connectivity.
d) In his theme address, Mr D Raghavan, Conference Chairman and Sector CEO (Healthcare), Siemens Ltd, pointed out that growth of insurance penetration from 25% in 2011 to 35% in 2016 would add another 120 million healthcare seekers. Healthcare providers were going through a paradigm shift assisted by the advances in medical technology. He called upon all stakeholders to collaborate and meet the challenges of affordability, accessibility and education.
e) Issues of education and training were brought up by several of the panelists who felt that this was key in widening the market and improving efficacy of outcomes. Mr Mark Rooney, Vice-President & MD, India Subcontinent, Covidien Healthcare India, said that practitioners need to be trained in use and real benefits of the technology. Mr Gautam Khanna, Executive Director, 3M India Ltd, pointed to the shortage of healthcare professionals like nurses and clinicians and advocated refresher trainings in new technology solutions so as to improve productivity
f) Mr Ajay Pitre, Chairman CII Medical Equipment Division and Managing Director, Sushrut Adler Group, said that the focus should be on innovation to achieve improved efficacy and delivery. To uphold quality, he said the CII was working on a code of ethics for the medical equipment sector.
g) Dr Ajay Bakshi, CEO, MAX Healthcare Ltd, asked for greater innovation in the business model covering the wide space of preventive, diagnostic curative and end-of-life needs. He called for solutions, rather than products.
h) Dr Bishnu Prasad Panigrahi, Group Head-Medical Operations, Fortis Hospital Ltd, suggested that manufacturing centres could be opened in India to lower costs and that specifications could be customized to Tier 2-3 cities.
i) Mr Jaideep Gupta, Managing Director, Apollo Hospitals, Delhi, suggested that there should be greater partnership and dialogue between healthcare providers and medical equipment companies. This was echoed by Dr Balbir Singh, Chairman, Electrophysiology & Pacing, Medanta Medicity, who said the partnership should work towards the patients’ benefit.
CII organized the 5th Medical Technology Conference on 24 August, 2012 at New Delhi.
The Indian Medical Technology industry has taken impressive strides in recent years. Growing at a CAGR of 15.6%, the size of the industry is expected to touch $14 billion by 2020 from current levels of $ 3 billion. Besides basic economic fundamentals, a key growth driver is the increase in the overall healthcare industry, which in turn is driven by an increased burden of lifestyle diseases, higher public spending, private investments in healthcare and increased penetration of health insurance. Industry reports suggest that the epicenter of technology and innovation is shifting towards emerging economies like India and China. Engineering excellence, cost-effective labour, increasing emphasis on intellectual property rights, easier accessibility to the Asian markets and a fast growing domestic market, makes India an ideal manufacturing base and the potential of becoming a global provider of medical devices.
You will get access to following Knowledge Resources by subscribing to the Digital
Library of this event.